For success in early clinical development, it’s critical to find the right participants, target dose/exposure, response and commercial strategy. A tailored delivery model that is proactive and scalable can help you meet these challenges – and accelerate your Phase I trial or program. Improve your probability of success with QuintilesIMS’s global drug development expertise, deep Phase I-IIa experience, and unmatched global network of sites.